The new pill form of popular GLP-1 drugs contains a compound that could cause troubling side effects. Historically, semaglutide, the active ingredient in Ozempic and Wegovy, has been administered via ...

Compounded semaglutide, meanwhile, contains the same active ingredient as Ozempic, semaglutide. However, this medication is not approved by the FDA, and it may pose risks to those who take it, ...

The Food and Drug Administration (“FDA”) has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can meet present and future demand. On February ...

Add Yahoo as a preferred source to see more of our stories on Google. In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to Ozempic—called ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and ...

Semaglutide is the active ingredient in certain brand-name medications prescribed for obesity, type 2 diabetes, and more. Semaglutide belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist ...

High demand and cost of legitimate GLP-1 drugs like Ozempic and Wegovy have fueled a counterfeit market. Consumers are urged to be cautious when purchasing GLP-1 drugs online and to report any ...